JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB38513

Anti-AKT2 (phospho S474) antibody

5

(6 Reviews)

|

(30 Publications)

Rabbit Polyclonal AKT2 phospho S474 antibody. Suitable for IHC-P, WB and reacts with Human samples. Cited in 30 publications. Immunogen corresponding to Synthetic Peptide within Human AKT2 phospho S474 aa 400 to C-terminus.

View Alternative Names

RAC-beta serine/threonine-protein kinase, Protein kinase Akt-2, Protein kinase B beta, RAC protein kinase beta, PKB beta, RAC-PK-beta, AKT2

4 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-AKT2 (phospho S474) antibody (AB38513)
  • IHC-P

AbReview43999****

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-AKT2 (phospho S474) antibody (AB38513)

ab38513 staining AKT2 in human infantile fibromatosis tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections). Tissue was fixed with formaldehyde and blocked with 1% FBS/BSA for 3 hours at room temperature; antigen retrieval was by heat mediation in Tris pH 9. Samples were incubated with primary antibody (1/150 in TBS + 1% BSA + 1% FBS) for 16 hours. An undiluted HRP-conjugated goat anti-rabbit IgG polyclonal was used as the secondary antibody.

This image is courtesy of an anonymous Abreview

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-AKT2 (phospho S474) antibody (AB38513)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-AKT2 (phospho S474) antibody (AB38513)

This image shows human lung carcinoma tissue stained with ab38513 at 1/50 dilution.

Image on left : untreated.

Image on right : treated with phosphopeptide at 1μg/ml (negative control).

Western blot - Anti-AKT2 (phospho S474) antibody (AB38513)
  • WB

Unknown

Western blot - Anti-AKT2 (phospho S474) antibody (AB38513)

Lanes can be loaded with 5-30µg of total protein.

All lanes:

Western blot - Anti-AKT2 (phospho S474) antibody (ab38513) at 1/500 dilution

Lane 1:

Extract of A2780 cells at 30 µg

Lane 2:

Extract of A2780 cells + TNF alpha at 30 µg

Lane 3:

Extract of A2780 cells + UV at 30 µg

Secondary

All lanes:

Alkaline Phosphatase AffiniPure Goat Anti-Rabbit IgG (H+L)

Predicted band size: 55 kDa

Observed band size: 60 kDa

false

Western blot - Anti-AKT2 (phospho S474) antibody (AB38513)
  • WB

Supplier Data

Western blot - Anti-AKT2 (phospho S474) antibody (AB38513)

All lanes:

Western blot - Anti-AKT2 (phospho S474) antibody (ab38513)

Lane 1:

293 cells treated for 30 min with 200ng/ml EGF

Lane 2:

293 cells treated for 30 min with 200ng/ml EGF with Phospho peptide

Predicted band size: 55 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, IHC-P

applications

Immunogen

Synthetic Peptide within Human AKT2 phospho S474 aa 400 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.

P31751

Specificity

Akt2 (phospho-Ser474) antibody detects endogenous levels of Akt2 only when phosphorylated at serine 474. The region of AKT2 surrounding S474 has a high degree of similarity to the corresponding regions in AKT1 and AKT3 and thus may cross react with these proteins if phosphorylated on the corresponding serine residue.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/50 - 1/100", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/1000", "WB-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Purification notes
The antibody was affinity purified from rabbit antiserum by affinity chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.87% Sodium chloride
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The AKT2 protein also known as protein kinase B beta is a serine/threonine kinase with a mass of approximately 56 kDa. It plays a critical mechanical role in cell survival and cell growth. AKT2 is an isoform of the AKT family and shares structural similarity with other AKT proteins. It is widely expressed in various tissues with high levels in insulin-responsive tissues such as skeletal muscle adipose tissue and liver. The AKT2 protein is an essential component in transmitting cellular signals related to growth and metabolism.
Biological function summary

The protein engages in controlling glucose transport and metabolism. As part of its biological functions AKT2 becomes phosphorylated and activated in response to insulin signaling and does not work as a part of a larger complex but interacts with other proteins. It plays a significant role in maintaining normal insulin sensitivity in tissues by facilitating the uptake and storage of glucose. Additionally the protein influences cell cycle progression and can affect apoptotic responses contributing to processes like protein synthesis and cell proliferation.

Pathways

AKT2 involves signaling mechanisms that include the PI3K/AKT/mTOR pathway and the insulin signaling pathway. These pathways are deeply connected to cellular growth and metabolic regulation. AKT2 works closely with proteins such as PI3K which phosphorylates phosphoinositides and mTOR that control protein synthesis by activating downstream targets. These interactions highlight the integration of AKT2 in nutrient-sensing pathways and how it aids the regulation of energy status in response to external stimuli.

AKT2 is notably linked to conditions such as type 2 diabetes and cancer. These diseases often involve dysregulated signaling pathways where AKT2 plays a significant role. In type 2 diabetes AKT2's link to insulin signaling becomes critical and its aberrant activity can lead to insulin resistance. In cancer the AKT2 protein interacts with PTEN a tumor suppressor that negatively regulates the PI3K/AKT pathway often leading to unregulated cell growth when mutated or inhibited. The understanding of AKT2's involvement in these diseases assists in developing potential therapeutic strategies targeting its dysregulation.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Serine/threonine kinase closely related to AKT1 and AKT3. All 3 enzymes, AKT1, AKT2 and AKT3, are collectively known as AKT kinase. AKT regulates many processes including metabolism, proliferation, cell survival, growth and angiogenesis, through the phosphorylation of a range of downstream substrates. Over 100 substrates have been reported so far, although for most of them, the precise AKT kinase catalyzing the reaction was not specified. AKT regulates glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface. Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling. Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport. AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity. Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven. AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating mTORC1 signaling and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1. AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization. In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319'. FOXO3 and FOXO4 are phosphorylated on equivalent sites. AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1. AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis. Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis. Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity. The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth. AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation. Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1). AKT mediates the antiapoptotic effects of IGF1. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly. May be involved in the regulation of the placental development (PubMed : 21432781, PubMed : 21620960). In response to lysophosphatidic acid stimulation, inhibits the ciliogenesis cascade. In this context, phosphorylates WDR44, hence stabilizing its interaction with Rab11 and preventing the formation of the ciliogenic Rab11-FIP3-RAB3IP complex. Also phosphorylates RAB3IP/Rabin8, thus may affect RAB3IP guanine nucleotide exchange factor (GEF) activity toward Rab8, which is important for cilia growth (PubMed : 31204173). Phosphorylates PKP1, facilitating its interaction with YWHAG and translocation to the nucleus, ultimately resulting in a reduction in keratinocyte intercellular adhesion (By similarity). Phosphorylation of PKP1 increases PKP1 protein stability, translocation to the cytoplasm away from desmosome plaques and PKP1-driven cap-dependent translation (PubMed : 23444369).. Several AKT2-specific substrates have been identified, including ANKRD2, C2CD5, CLK2 and PITX2. May play a role in myoblast differentiation. In this context, may act through PITX2 phosphorylation. Unphosphorylated PITX2 associates with an ELAVL1/HuR-containing complex, which stabilizes CCND1 cyclin mRNA, ensuring cell proliferation. Phosphorylation by AKT2 impairs this association, leading to CCND1 mRNA destabilization and progression towards differentiation (By similarity). Also involved in the negative regulation of myogenesis in response to stress conditions. In this context, acts by phosphorylating ANKRD2 (By similarity). May also be a key regulator of glucose uptake. Regulates insulin-stimulated glucose transport by the increase of glucose transporter GLUT4 translocation from intracellular stores to the plasma membrane. In this context, acts by phosphorylating C2CD5/CDP138 on 'Ser-197' in insulin-stimulated adipocytes (By similarity). Through the phosphorylation of CLK2 on 'Thr-343', involved in insulin-regulated suppression of hepatic gluconeogenesis (By similarity).
See full target information AKT2 phospho S474

Publications (30)

Recent publications for all applications. Explore the full list and refine your search

Pharmacology research & perspectives 12:e1160 PubMed38174807

2024

The blockade of the TGF-β pathway alleviates abnormal glucose and lipid metabolism of lipodystrophy not obesity.

Applications

Unspecified application

Species

Unspecified reactive species

Wen-Dong Xu,Shui-Zheng Lai,Jia Zhao,Shi-Jie Wei,Xue-Ying Fang,Yi-Yi Liu,Xiang-Lu Rong,Jiao Guo

Cell death & disease 14:564 PubMed37633911

2023

MiR-297 inhibits tumour progression of liver cancer by targeting PTBP3.

Applications

Unspecified application

Species

Unspecified reactive species

Na Lu,Jiali Min,Lin Peng,Shengjian Huang,Xiahua Chai,Susu Wang,Jian Wang

Cell stem cell 30:867-884.e11 PubMed37209681

2023

Multimodal characterization of murine gastruloid development.

Applications

Unspecified application

Species

Unspecified reactive species

Simon Suppinger,Marietta Zinner,Nadim Aizarani,Ilya Lukonin,Raphael Ortiz,Chiara Azzi,Michael B Stadler,Stefano Vianello,Giovanni Palla,Hubertus Kohler,Alexandre Mayran,Matthias P Lutolf,Prisca Liberali

Open life sciences 18:20220588 PubMed37077346

2023

Interaction between the PI3K/AKT pathway and mitochondrial autophagy in macrophages and the leukocyte count in rats with LPS-induced pulmonary infection.

Applications

Unspecified application

Species

Unspecified reactive species

Chao Wu,Lianghua Guo,Xirennayi Muhataer,Qifeng Li,Zhichuang Lian,Yafang Li,Wenyi Wang,Wei Ding,Yuan Zhou,Xiaohong Yang,Muzhi Chen

International journal of oncology 59: PubMed34476495

2021

MicroRNA‑93 knockdown inhibits acute myeloid leukemia cell growth via inactivating the PI3K/AKT pathway by upregulating DAB2.

Applications

Unspecified application

Species

Unspecified reactive species

Jiwei Huang,Ruozhi Xiao,Xiaozhen Wang,Bijay Khadka,Zhigang Fang,Mingxue Yu,Ling Zhang,Jieying Wu,Jiajun Liu

Experimental and therapeutic medicine 22:868 PubMed34194546

2021

MicroRNA-29b participates in the epithelial-mesenchymal transition of retinal pigment epithelial cells through p-p65.

Applications

Unspecified application

Species

Unspecified reactive species

Min Li,Hui Li,Shuai Yang,Xin Liao,Chun Zhao,Fang Wang

Annals of translational medicine 9:557 PubMed33987255

2021

Inhibition of bone morphogenetic protein receptor 2 suppresses pancreatic ductal adenocarcinoma growth by regulating GRB2/PI3K/AKT axis.

Applications

Unspecified application

Species

Unspecified reactive species

Yazhou Wang,Huahu Guo,Zhengkui Zhang,Qi Wang,Xiaodong Tian,Yinmo Yang

Cell & bioscience 10:72 PubMed32489586

2020

Metoprolol alleviates arginine vasopressin-induced cardiomyocyte hypertrophy by upregulating the AKT1-SERCA2 cascade in H9C2 cells.

Applications

Unspecified application

Species

Unspecified reactive species

Jieqiong Zhao,Yonghong Lei,Yanping Yang,Haibo Gao,Zhongchao Gai,Xue Li

International journal of nanomedicine 15:3605-3620 PubMed32547017

2020

Magnetic Targeting of HU-MSCs in the Treatment of Glucocorticoid-Associated Osteonecrosis of the Femoral Head Through Akt/Bcl2/Bad/Caspase-3 Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Lian Duan,Jianlin Zuo,Fuqiang Zhang,Binxi Li,Zhonghang Xu,Hao Zhang,Bai Yang,Wenzhi Song,Jinlan Jiang

International journal of molecular sciences 21: PubMed32397282

2020

Therapeutic Effect of Rapamycin on Aortic Dissection in Mice.

Applications

Unspecified application

Species

Unspecified reactive species

Makiko Hayashi-Hori,Hiroki Aoki,Miho Matsukuma,Ryohei Majima,Yohei Hashimoto,Sohei Ito,Saki Hirakata,Norifumi Nishida,Aya Furusho,Satoko Ohno-Urabe,Yoshihiro Fukumoto
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com